Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celldex Therapeutics (CLDX) Goodwill (2016 - 2017)

Historic Goodwill for Celldex Therapeutics (CLDX) over the last 8 years, with Q4 2017 value amounting to $91.0 million.

  • Celldex Therapeutics' Goodwill changed 0.0% to $91.0 million in Q4 2017 from the same period last year, while for Dec 2017 it was $91.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $91.0 million for FY2017, which is 0.0% changed from last year.
  • Per Celldex Therapeutics' latest filing, its Goodwill stood at $91.0 million for Q4 2017, which was down 0.0% from $91.0 million recorded in Q3 2017.
  • Celldex Therapeutics' 5-year Goodwill high stood at $91.0 million for Q4 2016, and its period low was $9.0 million during Q1 2013.
  • Moreover, its 5-year median value for Goodwill was $9.0 million (2013), whereas its average is $29.5 million.
  • Its Goodwill has fluctuated over the past 5 years, first changed by 0.0% in 2013, then soared by 91479.09% in 2016.
  • Celldex Therapeutics' Goodwill (Quarter) stood at $9.0 million in 2013, then changed by 0.0% to $9.0 million in 2014, then changed by 0.0% to $9.0 million in 2015, then soared by 914.79% to $91.0 million in 2016, then changed by 0.0% to $91.0 million in 2017.
  • Its Goodwill stands at $91.0 million for Q4 2017, versus $91.0 million for Q3 2017 and $91.0 million for Q2 2017.